Диссертация (1174263), страница 19
Текст из файла (страница 19)
Antal-Szalmaґs// Eur J Clin Invest. – 2000. – Vol. 30 – P.167–79.22.Bas S.CD14 is an acute phase protein [Text] / S. Bas, B.R. Gauthier, U. Spenato[et al.] // J Immunol. - 2004. - Vol.172. - P. 4470–4479.12923.Laborde G. Nosocomial infections in a neurosurgical intensive care unit [Text] /G. Laborde, U. Grosskopf, K. Schmieder [et al.] // Anaesthesist. – 1993 – Vol.42 N.10 – P.
724–3124.Donmez H. Stroke secondary to aseptic meningitis after endovascular treatment ofa giant aneurysm with parent artery occlusion [Text] / H. Donmez, E. Mavili, T.Ikizceli [et al.] // Cardiovasc Intervent Radiol. 2009 – Vol. 32 – P. 801-3.25.Dettenkofer M. Nosocomial infections in a neurosurgery intensive care unit [Text]/ M. Dettenkofer, V. Ebner, F.J. Hans [et al.] // Acta Neurochir. – 1999 - Vol.141– N.12- P.1303–8.26.Bercault N. Mortality rate attributable to ventilator-associated nosocomialpneumonia in an adult intensive care unit: a prospective case-control study [Text]/ N.
Bercault, T. Boulain. // Crit Care Med. – 2001 - Vol.29 – N.12 - 2303–9.27.Hilker R. Nosocomial pneumonia after acute stroke: implications for neurologicalintensive care medicine [Text] / R. Hilker, C. Poetter, N. Findeisen [et al.] // Stroke.– 2003 – Vol.34 – N.4 – P. 975–81.28.Maramattom B.V.
Pulmonary complications after intracerebral hemorrhage [Text]/ B.V. Maramattom, S. Weigand, M. Reinalda [et al.] // Neurocrit Care. – 2006. Vol.5. – N.2. – P.115–9.29.Chastre J. Ventilator-associated pneumonia [Text] / J. Chastre, J.Y. Fagon // Am JRespir Crit Care Med.
– 2002 – Vol.165 - N.7 – P.867–903.30.Wang F. Survey on hospital-acquired urinary tract infection in neurologicalintensive care unit [Text] / F. Wang, T. Xing, J. Li, [et al.] // APMIS. – 2013 –Vol.121 -N.3 – P.197–201.13031.Dettenkofer M. Surveillance of nosocomial infections in a neurology intensive careunit [Text] / M. Dettenkofer, W. Ebner, T.
Els [et al.] //J Neurol. – 2001. - Vol.248- N.11 - P. 959–64.32.Hoefnagel D. Risk factors for infections related to external ventricular drainage[Text] / D. Hoefnagel, R. Dammers, M.P. Ter Laak-Poort [et al.] // Acta Neurochir.– 2008 – Vol.150 -N.3 – P. 209–14.33.Baraff L.J. Outcomes of bacterial meningitis in children: a meta-analysis [Text] /L.J. Baraff, S.I. Lee, D.L. Schriger // Pediatr Infect Dis J.
-1993 -Vol.12 – N.5 P.389–94.34.Grimwood K. Twelve year outcomes following bacterial meningitis: furtherevidence for persisting effects [Text] / K. Grimwood, P. Anderson, V. Anderson[et al.] // Arch Dis Child. – 2000 – Vol.83 -N.2 - P.111–6.35.Short W.R. Changing epidemiology of bacterial meningitis in the United States[Text] / W.R.
Short, A.R. Tunkel // Curr Infect Dis Rep. – 2000 – Vol.2 – N.4 P.327–31.36.van de Beek D. Community acquired bacterial meningitis in adults [Text] / D. vande Beek, J. de Gans, A.R. Tunkel [et al.] // N Engl J Med. – 2006 -Vol.354 -N.1 –P.
44–53.37.van de Beek D. Clinical features and prognostic factors in adults with bacterialmeningitis [Text] / D. van de Beek, J. de Gans, L. Spanjaard, [et al.] // N EnglJMed. – 2004 – Vol.351 – N.18 – P. 1849–59.38.Thigpen M.C. Bacterial meningitis in the United States, 1998–2007 [Text] / M.C.Thigpen, C.G. Whitney, N.E. Messonnier, [et al.] //N Engl J Med. – 2011 – Vol.364 – N.21 – P.2016–25.13139.Flores-Cordero J.M. Acute community-acquired bacterial meningitis in adultsadmitted to the intensive care unit: clinical manifestations, management andprognostic factors [Text] / J.M.
Flores-Cordero, R. Amaya-Villar, M.D. RincónFerrari [et al.] //Intensive Care Med. – 2003 - Vol.29 - N.11 – P.1967–73.40.Wang K.W. The significance of seizures and other predictive factors during theacute illness for the long-term outcome after bacterial meningitis [Text] / K.W.Wang, W.N. Chang, H.W. Chang [et al.] // Seizure. – 2005 – Vol.14 - N.8 - P.586–92.41.Kourbeti I.S. Risk factors associated with postcraniotomy meningitis [Text] / I.S.Kourbeti, A.V. Jacobs, M. Koslow [et al.]// Neurosurgery. – 2007 – Vol.60 -N.2 P.
317–25.42.Lyke K.E. Ventriculitis complicating use of intraventricular catheters in adultneurosurgical patients [Text] / K.E. Lyke, O.O. Obasanjo, M.A. Williams [et al.]//Clin Infect Dis. – 2001 – Vol.33 -N.12 - P.2028–33.43.Camacho E.F. Infection rate and risk factors associated with infections related toexternal ventricular drain [Text] / E.F. Camacho, I. Boszczowski, M. Basso [et al.]// Infection. – 2011 – Vol.39 -N.1 P.
47–51.44.Gelabert-Gonzalez M. The Camino intracranial pressure device in clinical practice.Assessment in a 1000 cases [Text] / M. Gelabert-Gonzalez, V. Ginesta-Galan, R.Sernamito-García [et al.] // Acta Neurochir. – 2006 – Vol.148 - N.4 – P. 435–41.45.Poca M.A. Fiberoptic intraparenchymal brain pressure monitoring with the CaminoV420 monitor: reflections on our experience in 163 severely head-injured patients[Text] / M.A. Poca, J. Sahuquillo, M. Arribas [et al.]// J Neurotrauma.
– 2002 Vol.19 - N. 4 - P. 439–48.13246.Fily F. Deep brain stimulation hardware-related infections: a report of 12 cases andreview of the literature [Text] / F. Fily, C. Haegelen, P. Tattevin [et al.]// Clin InfectDis. – 2011 - Vol.52 N.8 – P. 1020–3.47.Scully E.P. Fungal brain infections [Text] / E.P. Scully, L.R. Baden, J.T.
Katz //Curr Opin Neurol. – 2008 – Vol.21 – P. 347.48.Gadgil N. Intraventricular brain abscess [Text] / N. Gadgil, R.B. Chamoun, S.P.Gopinath // J Clin Neurosci. – 2012 – Vol.19 – N.9 -P.1314–6.49.Lozier A.P. Ventriculostomy-related infections: a critical review of the literature[Text] / A.P. Lozier, R.R. Sciacca, M.F. Romagnoli [et al.] // Neurosurgery. – 2002– Vol. 51 - P. 170–181.50.Stenehjem E. Central nervous system device infections [Text] / E. Stenehjem, W.S.Armstrong //Infect Dis Clin North Am. – 2012 - Vol. 26. – N.1 – P. 89–110.51.Ramanan M. A meta-analysis of ventriculostomy associated cerebrospinal fluidinfections [Text] / M.
Ramanan, J. Lipman, A. Shorr, [et al.] // BMC Infect Dis. 2015 – Vol.15. - P.3.52.Hanna H. Central venous catheter-related bacteremia due to gram-negative bacilli:significance of catheter removal in preventing relapse [Text] / H. Hanna, C. Afif,B. Alakech [et al.] //Infect Control Hosp Epidemiol. – 2004. – Vol.25. – N.8. – P.646–9.53.Briggs S. Gram-negative Bacillary Meningitis after Cranial Surgery or Trauma inAdults [Text] /S. Briggs, R. Ellis-Pegler, N. Raymond [et al.]– 2004. – Vol. 36. – P.165-173.// ScandJ Infect Dis.13354.Pendleton J.N.Clinical relevance of the ESKAPE Pathogens [Text] / J.N.Pendleton, B.F.
Gorman, B.F. Gilmore // Antimicrobial agents and chemotherapy.– 2013. – Vol.11, N. 3. – P. 297 – 308.55.Arias C.A. The rise of the Enterococcus: Beyond vancomycin resistance [Text] /C.A. Arias, B.E. Murray // Nat. Rev. Microbiol. – 2012. - Vol.10. P. 266-278.56.Saeidi S. Molecular epidemiology and antibiotic resistance patterns ofEnterococcus faecalis isolates from hospitals in Tehran [Text] / S.
Saeidi, R.Mirnejad, S. Masoumi Zavaryani, [et al.] // Infez. Med. – 2017. - Vol.25. - P. 116122.57.Mirnejad R. Identification of aminoglycoside resistance genes by Triplex PCR inEnterococcus spp. isolated from ICUs [Text] / R. Mirnejad, N. Sajjadi, MasoumiS. Zavaryani [et al.] // Infez. Med. – 2016. - Vol.24. - P.222-229.58.Vigani A.G. Clinical, epidemiological, and microbiological characteristics ofbacteremia caused by high-level gentamicin-resistant Enterococcus faecalis [Text]/ A.G. Vigani, A.M.
Oliveira, O.J. Bratfich, [et al.] // Braz. J. Med. Biol. Res. –2008. -Vol.41. - P.890-895.59.Ramsey A.M. Secular trends of hospitalization with vancomycin-resistantenterococcus infection in the United States, 2000 – 2006 [Text] / A.M. Ramsey,M.D. Zilberberg // Infect. Control Hosp. Epidemiol. – 2009. – Vol. 30. – P. 184 –186.60.Panesso D. Molecular epidemiology of vancomycin-resistant Enterococcusfaecium: a prospective, multicenter study in South American hospitals [Text] / D.Panesso, J. Reyes, S. Rincon, [et al.] // J.
Clin. Microbiol. – 2010. – Vol. 48. – P.1562 – 1569.13461.Thongkoom P. Vancomycin-resistant enterococci (VRE) isolates isolated inRajavithi Hospital between 1999 and 2009 [Text] / P. Thongkoom, S.Kanjanahareutai, S. Chantrakooptungool, [et al.] // J. Med. Assoc. Thai. – 2012. Vol. 95, N. – P. 7 – 15.62.Hawkey P.M. Molecular epidemiology of clinically significant antibioticresistance genes [Text] / P.M. Hawkey // Br. J. Pharmacol. 2008. – Vol.153.
P.406-413,63.Munita J.M. Evolving resistance among Gram-positive pathogens [Text] / J.M.Munita, A.S. Bayer, C.A. Arias // Clin. Infect. Dis. – 2015. - Vol. 61. – P. 48 – 57.64.Nikaido H. Multidrug resistance in bacteria [Text] / Nikaido H. // Annu. Rev.Biochem. – 2009. -Vol.78. – P.119-146.65.Tekin A. Assessment of methicillin and clindamycin resistance patterns inStaphylococcus aureus isolated from a tertiary hospital in Turkey. [Text] / A.Tekin, T. Dal, O. Deveci, [et al.] // Infez.
Med. 2013. – Vol. 21. – P.111-116.66.Appelbaum P.C. Microbiology of antibiotic resistance in Staphylococcus aureus[Text] / P.C. Appelbaum // Clin. Infect. Dis. 2007. – Vol.45. – P. 165 – 170.67.Callejo-Torre F. Risk factors for methicillin-resistant Staphylococcus aureuscolonisation or infection in intensive care units and their reliability for predictingMRSA on ICU admission [Text] / F. Callejo-Torre, J.M.
Eiros Bouza, P. OlaecheaAstigarraga, [et al.] // Infez. Med. – 2016. – Vol. 24. – P. 201 – 209.68.Paterson G.K. Prevalence and characterization of human mec C methicillinresistant Staphylococcus aureus isolates in England [Text] / G.K. Paterson, F.J.Morgan, E.M. Harrison [et al.] // J. Antimicrob. Chemother. – 2014. - Vol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
